Viriom   Report issue

For profit Phase 1 Phase 3
Founded: San Diego CA United States (2009)

Organization Overview

First Clinical Trial
2012
NCT02489435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Viriom